Abstract
Splenectomy for thrombocytopenia was performed in 6 patients in the chronic phase of chronic granulocytic leukemia. The operation was performed after a prolonged thrombocytopenia, with hemorrhagic manifestations due to busulfan-related myelosuppression unresponsive to corticosteroids and frequent platelet transfusions (2 patients), and the inability to control the clinical and hemato-logic manifestations of the disease because of inordinate platelet sensitivity to chemotherapy (4 patients). There was an immediate postoperative rise in platelet count in all 6 patients which was sustained in 5 patients. The rise was rapid in 3 cases. Spleen size did not correlate with the extent of postoperative recovery. In 5 patients with bleeding and thrombocytopenia, no further hemorrhagic problems or platelet transfusions were required as long as they remained in the chronic phase of CGL. Hydroxyurea was a useful drug to control CGL in patients markedly sensitive to the thrombocytopenic effects of busulfan.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
